• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

角膜炎:发病率、病理生理学、危险因素及新型治疗策略

Keratitis: Incidence, Pathophysiology, Risk Factors and Novel Strategies for Treatment.

作者信息

Lee Jason W, Somerville Tobi, Kaye Stephen B, Romano Vito

机构信息

School of Medicine, University of Liverpool, Liverpool L69 3GE, UK.

Department of Eye and Vision Science, University of Liverpool, Liverpool L7 8TX, UK.

出版信息

J Clin Med. 2021 Feb 13;10(4):758. doi: 10.3390/jcm10040758.

DOI:10.3390/jcm10040758
PMID:33668633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7918096/
Abstract

Bacterial keratitis is a devastating condition that can rapidly progress to serious complications if not treated promptly. Certain causative microorganisms such as and are notorious for their resistance to antibiotics. Resistant bacterial keratitis results in poorer outcomes such as scarring and the need for surgical intervention. Thorough understanding of the causative pathogen and its virulence factors is vital for the discovery of novel treatments to avoid further antibiotic resistance. While much has been previously reported on , has been less extensively studied. This review aims to give a brief overview of epidemiology, pathophysiology and clinical characteristics as well as summarise the current evidence for potential novel therapies.

摘要

细菌性角膜炎是一种严重的疾病,如果不及时治疗,会迅速发展为严重的并发症。某些致病微生物,如……和……,因其对抗生素的耐药性而臭名昭著。耐药性细菌性角膜炎会导致更差的预后,如瘢痕形成以及需要手术干预。全面了解致病病原体及其毒力因子对于发现新的治疗方法以避免进一步的抗生素耐药性至关重要。虽然之前已经有很多关于……的报道,但……的研究较少。本综述旨在简要概述……的流行病学、病理生理学和临床特征,并总结当前潜在新疗法的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/7918096/4c73320fa843/jcm-10-00758-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/7918096/53bc3da913ae/jcm-10-00758-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/7918096/68499809242f/jcm-10-00758-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/7918096/65da9f151bdb/jcm-10-00758-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/7918096/35b7b50a7a68/jcm-10-00758-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/7918096/4c73320fa843/jcm-10-00758-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/7918096/53bc3da913ae/jcm-10-00758-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/7918096/68499809242f/jcm-10-00758-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/7918096/65da9f151bdb/jcm-10-00758-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/7918096/35b7b50a7a68/jcm-10-00758-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85cb/7918096/4c73320fa843/jcm-10-00758-g005.jpg

相似文献

1
Keratitis: Incidence, Pathophysiology, Risk Factors and Novel Strategies for Treatment.角膜炎:发病率、病理生理学、危险因素及新型治疗策略
J Clin Med. 2021 Feb 13;10(4):758. doi: 10.3390/jcm10040758.
2
and P infectious keratitis: key bacterial mechanisms that mediate pathogenesis and emerging therapeutics.并探讨 P 型感染性角膜炎:介导发病机制的关键细菌机制和新兴治疗方法。
Front Cell Infect Microbiol. 2023 Aug 21;13:1250257. doi: 10.3389/fcimb.2023.1250257. eCollection 2023.
3
Microbial keratitis pathogens and antibiotic susceptibilities: a 5-year review of cases at an urban county hospital in north Texas.微生物性角膜炎病原体及抗生素敏感性:对德克萨斯州北部一家城市县级医院5年病例的回顾
Eye Contact Lens. 2007 Jan;33(1):45-9. doi: 10.1097/01.icl.0000234002.88643.d0.
4
Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.铜绿假单胞菌和葡萄球菌角膜感染分离株对环丙沙星、庆大霉素和头孢菌素耐药性的综述。
Clin Exp Optom. 2011 Mar;94(2):161-8. doi: 10.1111/j.1444-0938.2010.00536.x. Epub 2010 Nov 17.
5
Corneal ulceration in pediatric patients: a brief overview of progress in topical treatment.小儿患者的角膜溃疡:局部治疗进展简述
Paediatr Drugs. 2002;4(2):95-110. doi: 10.2165/00128072-200204020-00003.
6
A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.在葡萄球菌性和铜绿假单胞菌性角膜炎兔模型中,局部应用洗必泰、环丙沙星以及强化妥布霉素/头孢唑林的比较。
J Ocul Pharmacol Ther. 2007 Jun;23(3):213-20. doi: 10.1089/jop.2006.81.
7
Ten-year analysis of microbiological profile and antibiotic sensitivity for bacterial keratitis in Korea.韩国细菌性角膜炎的十年微生物谱和抗生素敏感性分析。
PLoS One. 2019 Mar 1;14(3):e0213103. doi: 10.1371/journal.pone.0213103. eCollection 2019.
8
An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.一项使用金黄色葡萄球菌和铜绿假单胞菌角膜炎分离株对左氧氟沙星、环丙沙星和氧氟沙星进行的体外耐药性研究。
Ophthalmology. 2001 Oct;108(10):1826-9. doi: 10.1016/s0161-6420(01)00724-2.
9
and microbial keratitis.并发性微生物角膜炎。
J Med Microbiol. 2020 Jan;69(1):3-13. doi: 10.1099/jmm.0.001110.
10
Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.广谱抗菌组合药物的开发用于治疗金黄色葡萄球菌和铜绿假单胞菌角膜感染。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01929-18. Print 2019 Jan.

引用本文的文献

1
TRPV1 Defends the Healthy Murine Cornea Against Staphylococcus aureus Adhesion Independently of Sensory Nerve Firing.瞬时受体电位香草酸亚型1(TRPV1)独立于感觉神经放电,保护健康的小鼠角膜免受金黄色葡萄球菌粘附。
Invest Ophthalmol Vis Sci. 2025 Jul 1;66(9):61. doi: 10.1167/iovs.66.9.61.
2
The antibiotic resistance profiles of Staphylococcus in the Asia Cornea Society infectious keratitis study.亚洲角膜学会感染性角膜炎研究中葡萄球菌的抗生素耐药谱
Int Ophthalmol. 2025 Jul 22;45(1):309. doi: 10.1007/s10792-025-03667-3.
3
Ion-paired moxifloxacin nanocrystal formulation improves treatment and prevention of ocular infection.

本文引用的文献

1
Recurrent microbial keratitis and endogenous site Staphylococcus aureus colonisation.复发性微生物角膜炎与内源性定植的金黄色葡萄球菌。
Sci Rep. 2020 Oct 29;10(1):18559. doi: 10.1038/s41598-020-75821-z.
2
Cross-Linking Assisted Infection Reduction (CLAIR): A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Bacterial Keratitis.交联辅助感染减少(CLAIR):一项评估辅助交联对细菌性角膜炎影响的随机临床试验。
Cornea. 2021 Jul 1;40(7):837-841. doi: 10.1097/ICO.0000000000002510.
3
Evaluation of Toluidine Blue-Mediated Photodynamic Therapy for Experimental Bacterial Keratitis in Rabbits.
离子对莫西沙星纳米晶制剂改善眼部感染的治疗与预防。
J Control Release. 2025 May 10;381:113634. doi: 10.1016/j.jconrel.2025.113634. Epub 2025 Mar 15.
4
Characterization of infectious bacterial keratitis in Östergötland County, Sweden: a 10-year retrospective study.瑞典东约特兰省感染性细菌性角膜炎的特征:一项10年回顾性研究
J Ophthalmic Inflamm Infect. 2024 Oct 7;14(1):49. doi: 10.1186/s12348-024-00432-y.
5
Contact Lens Associated Bacterial Keratitis: Common Organisms, Antibiotic Therapy, and Global Resistance Trends: A Systematic Review.隐形眼镜相关性细菌性角膜炎:常见病原体、抗生素治疗及全球耐药趋势:一项系统评价
Front Ophthalmol (Lausanne). 2021 Dec 1;1:759271. doi: 10.3389/fopht.2021.759271. eCollection 2021.
6
A comparison of antimicrobial regimen outcomes and antibiogram development in microbial keratitis: a prospective cohort study in Alexandria, Egypt.埃及亚历山大微生物角膜炎的抗生素方案结果和药敏谱发展比较:前瞻性队列研究。
Graefes Arch Clin Exp Ophthalmol. 2024 Jun;262(6):1865-1882. doi: 10.1007/s00417-023-06362-0. Epub 2024 Jan 19.
7
and P infectious keratitis: key bacterial mechanisms that mediate pathogenesis and emerging therapeutics.并探讨 P 型感染性角膜炎:介导发病机制的关键细菌机制和新兴治疗方法。
Front Cell Infect Microbiol. 2023 Aug 21;13:1250257. doi: 10.3389/fcimb.2023.1250257. eCollection 2023.
8
Corticosteroid-Antibiotic Interactions in Bacteria that Cause Corneal Infection.引起角膜感染的细菌中的皮质类固醇-抗生素相互作用。
Transl Vis Sci Technol. 2023 May 1;12(5):16. doi: 10.1167/tvst.12.5.16.
9
Microbiological Profile in Patients Having Keratitis in a Tertiary Care Hospital in India.印度一家三级护理医院角膜炎患者的微生物学特征
Cureus. 2022 Nov 18;14(11):e31653. doi: 10.7759/cureus.31653. eCollection 2022 Nov.
10
Anti- activity of a semi-synthetic mangostin derivative and its ability in removal of WU19001 on contact lens.半合成倒捻子素衍生物的抗活性及其在接触镜上清除 WU19001 的能力。
PeerJ. 2022 Dec 9;10:e14468. doi: 10.7717/peerj.14468. eCollection 2022.
甲苯胺蓝介导的光动力疗法治疗兔实验性细菌性角膜炎的评估。
Transl Vis Sci Technol. 2020 Feb 12;9(3):13. doi: 10.1167/tvst.9.3.13.
4
Corneal collagen cross-linking for bacterial infectious keratitis.用于细菌性感染性角膜炎的角膜胶原交联术
Cochrane Database Syst Rev. 2020 Jun 17;6(6):CD013001. doi: 10.1002/14651858.CD013001.pub2.
5
pHEMA@AGMNA-1: A novel material for the development of antibacterial contact lens.pHEMA@AGMNA-1:一种用于开发抗菌隐形眼镜的新型材料。
Mater Sci Eng C Mater Biol Appl. 2020 Jun;111:110770. doi: 10.1016/j.msec.2020.110770. Epub 2020 Feb 24.
6
Methicillin-Resistant Staphylococcus aureus Keratitis: Initial Treatment, Risk Factors, Clinical Features, and Treatment Outcomes.耐甲氧西林金黄色葡萄球菌角膜炎:初始治疗、危险因素、临床特征和治疗结果。
Am J Ophthalmol. 2020 Jun;214:119-126. doi: 10.1016/j.ajo.2020.03.017. Epub 2020 Mar 21.
7
The role of staphopain a in Staphylococcus aureus keratitis.葡萄球菌蛋白酶 A 在金黄色葡萄球菌角膜炎中的作用。
Exp Eye Res. 2020 Apr;193:107994. doi: 10.1016/j.exer.2020.107994. Epub 2020 Mar 5.
8
Treatment-Resistant Bacterial Keratitis: Challenges and Solutions.耐治疗性细菌性角膜炎:挑战与解决方案
Clin Ophthalmol. 2020 Jan 29;14:287-297. doi: 10.2147/OPTH.S181997. eCollection 2020.
9
Vancomycin resistant infections: A review of case updating and clinical features.耐万古霉素感染:病例更新与临床特征综述
J Adv Res. 2019 Oct 12;21:169-176. doi: 10.1016/j.jare.2019.10.005. eCollection 2020 Jan.
10
and microbial keratitis.并发性微生物角膜炎。
J Med Microbiol. 2020 Jan;69(1):3-13. doi: 10.1099/jmm.0.001110.